Showing 1765 results
-
Story /This is the story of how three Novartis colleagues took a career decision to improve health in lower income countries.
-
Story /Novartis’ Don Ganem tapped as a scientific advisor for the Chan Zuckerberg Biohub
-
Story /Melanoma survivor T.J. Sharpe discusses his personal experience with cancer and the important role caregivers play in a patient’s road to recovery.
-
Story /A Novartis team couriers an experimental treatment across Europe to a patient as transit grinds to a halt.
-
Press release /Cosentyx is the first and only IL-17A inhibitor from a new class of medicines shown to treat two of the most common inflammatory joint conditions in Europe[1] Cosentyx shows rapid and…
-
Press release /EU approval is based on two Phase III studies showing Cosentyx® provides fast and strong skin clearance, along with significant improvement in quality of life and a favorable safety profile1 …